Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding Mode. (2020)
Attributed to:
Accelerated Discovery and Development of New Medicines: Prosperity Partnership for a Healthier Nation
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.0c00021
PubMed Identifier: 32321240
Publication URI: http://europepmc.org/abstract/MED/32321240
Type: Journal Article/Review
Volume: 63
Parent Publication: Journal of medicinal chemistry
Issue: 10
ISSN: 0022-2623